Class of Stock [Axis]
Common Stock, $0.001 par value per share [Member]
8.625% Senior Notes due 2026 [Member]
11.875% Senior Notes due 2027 [Member]
Product and Service [Axis]
Product Sales Net [Member]
Other Revenues [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Antidilutive Securities [Axis]
Stock Options, Unvested RSUs And Unvested PSUs [Member]
Award Type [Axis]
Restricted Stock Units (RSUs) [Member]
Title and Position [Axis]
Director [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Debt Instrument [Axis]
2026 Notes [Member]
2027 Notes [Member]
Fair Value, Inputs, Level 2 [Member]
Oaktree Loan [Member]
Restricted Stock [Member]
Equity Option [Member]
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
Chargebacks [Member]
Government Rebates [Member]
Allowances For Sales Returns [Member]
Administrative Fees and Other Rebates [Member]
Co Pay Assistance [Member]
Reserves For Cash Discount [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
Capitalized Software Development Costs [Member]
Third Party Software License [Member]
Patents [Member]
Licenses [Member]
Trademarks [Member]
Acquired NDAs [Member]
Customer Relationships [Member]
Trade Names [Member]
State Pharmacy Licenses [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Legal Entity [Axis]
Oaktree Fund Administration LLC [Member]
Long-Term Debt, Type [Axis]
Senior Secured Term Loan [Member]
Credit Facility [Axis]
Tranche B [Member]
Oaktree Credit Agreement Amendment [Member]
Business Combination [Axis]
Santen Products Acquisition [Member]
Second Amendment [Member]
Statistical Measurement [Axis]
Maximum [Member]
8.625% Senior Notes Due 2026 [Member]
Investor [Member]
11.875% Senior Notes Due 2027 [Member]
Oaktree Loan due January 2026 [Member]
Senior Notes Due April 2026 [Member]
Minimum [Member]
Long-Lived Tangible Asset [Axis]
Office and Laboratory Space [Member]
Geographical [Axis]
Ledgewood [Member]
Nashville [Member]
Statement of Income Location, Balance [Axis]
Selling, General and Administrative Expenses [Member]
Related and Nonrelated Parties [Axis]
Andrew R. Boll [Member]
Performance Shares [Member]
Award Date [Axis]
April 2023 [Member]
Mark L. Baum [Member]
John P Saharek [Member]
Prior Periods [Member]
RSU And PSU [Member]
Share-Based Payment Arrangement, Option [Member]
Employees and Consultant [Member]
Employees and Directors [Member]
Stock Option Plan [Member]
Exercise Price Range [Axis]
Range One [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Range Six [Member]
Range Seven [Member]
Range Eight [Member]
Range Nine [Member]
Range Ten [Member]
Employees [Member]
Research and Development Expense [Member]
Consultants [Member]
Formosa Agreement [Member]
Asset Purchase, License and Related Agreements [Member]
Asset Purchase and License Agreements [Member]
Scenario [Axis]
Forecast [Member]
Segments [Axis]
Branded [Member]
Compounding [Member]
Consolidation Items [Axis]
Operating Segments [Member]
Corporate Segment [Member]
Reportable Segment Aggregation Research and Development [Member]
IHEEZO [Member]
VEVYE [Member]
Other Products [Member]
Other Revenue [Member]
ImprimisRx [Member]
Customer [Axis]
Two Customer [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
One Customer [Member]
Customer [Member]
Two Suppliers [Member]
Purchases [Member]
Supplier Concentration Risk [Member]
Three Suppliers [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Chief Executive Officer [Member]
Performance Stock Units PSU [Member]
Vesting [Axis]
Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Payment Arrangement, Tranche Three [Member]
Share Based Compensation Award Tranche Four [Member]
Statement [Table]
Statement [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Statement of Financial Position [Abstract]
ASSETS
Current assets
Cash and cash equivalents
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, net
Capitalized software costs, net
Operating lease right-of-use assets, net
Intangible assets, net
Goodwill
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued expenses
Accrued rebates and copay assistance
Accrued payroll and related liabilities
Deferred revenue and customer deposits
Current portion of notes payable, net of unamortized debt discount
Current portion of operating lease obligations
Total current liabilities
Operating lease obligations, net of current portion
Notes payable, net of unamortized debt discount and current portion
TOTAL LIABILITIES
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 50,000,000 shares authorized, 36,714,679 and 35,622,214 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively
Additional paid-in capital
Accumulated deficit
TOTAL HARROW, INC. STOCKHOLDERS’ EQUITY
Noncontrolling interests
TOTAL STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Revenues:
Total revenues
Cost of sales
Gross profit
Operating expenses:
Selling, general and administrative
Research and development
Total operating expenses
Income (loss) from operations
Other (expense) income:
Interest expense, net
Investment loss from Eton Pharmaceuticals
Other (expense) income, net
Total other expense, net
Income (loss) before income taxes
Income tax expense
Net income (loss)
Basic net income (loss) per share of common stock
Diluted net income (loss) per share of common stock
Weighted average number of shares of common stock outstanding, basic
Weighted average number of shares of common stock outstanding, diluted
Balance
Balance, shares
Exercise of employee stock-based options
Exercise of employee stock-based options, shares
Vesting of RSUs and PSUs
Vesting of RSUs and PSUs, shares
Shares withheld related to net share settlement of equity awards
Shares withheld related to net share settlement of equity awards, shares
Stock-based compensation expense
Net income (loss)
Balance
Balance, shares
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization of property, plant and equipment and software development costs
Amortization of intangible assets
Amortization of operating lease right-of-use assets
Provision for (recovery of) credit losses
Amortization of debt issuance costs and debt discount
Investment loss from investment in Eton Pharmaceuticals
Stock-based compensation
Deferred income tax
Changes in assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Accounts payable, accrued expenses, accrued rebates and copay assistance
Accrued payroll and related liabilities
Deferred revenue and customer deposits
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
CASH FLOWS FROM INVESTING ACTIVITIES
Net proceeds on sale of investment in Eton Pharmaceuticals
Investment in patent and trademark assets
Purchases of property, plant and equipment
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Payment of payroll taxes upon vesting of PSUs, RSUs and exercise of stock options
Proceeds from exercise of stock options
Payment of debt issuance costs
NET CASH USED IN FINANCING ACTIVITIES
NET CHANGE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, beginning of period
CASH, CASH EQUIVALENTS, end of period
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes
Cash paid for interest
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Purchase of property, plant and equipment included in accounts payable and accrued expenses
Change in right-of-use assets for operating lease obligations assumptions
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Trading Arrangements, by Individual [Table]
Trading Arrangement [Axis]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Accounting Policies [Abstract]
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Revenue from Contract with Customer [Abstract]
REVENUES
Inventory Disclosure [Abstract]
INVENTORIES
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSES AND OTHER CURRENT ASSETS
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT
Capitalized Software Costs
CAPITALIZED SOFTWARE COSTS
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS AND GOODWILL
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
Debt Disclosure [Abstract]
DEBT
Leases
LEASES
Equity [Abstract]
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Segment Reporting [Abstract]
SEGMENTS AND CONCENTRATIONS
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Risks, Uncertainties and Liquidity
Credit Losses
Fair Value Measurements
Basic and Diluted Net Income (Loss) per Common Share
Income Taxes
Accounting Guidance Issued but Not Adopted at June 30, 2025
SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE OF CREDIT LOSS
SCHEDULE OF ESTIMATED FAIR VALUE
SCHEDULE OF BASIC EARNINGS PER COMMON SHARE
SCHEDULE OF DILUTED NET INCOME PER SHARE
SCHEDULE OF BASIC AND DILUTED EARNINGS PER COMMON SHARE
SCHEDULE OF ACCRUALS AND ALLOWANCES
SCHEDULE OF DISAGGREGATED REVENUE
SCHEDULE OF INVENTORIES
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT
SCHEDULE OF CAPITALIZED SOFTWARE COSTS
SCHEDULE OF INTANGIBLE ASSETS
SCHEDULE OF AMORTIZATION EXPENSES FOR INTANGIBLE ASSETS
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES
SCHEDULE OF LONG TERM DEBT
SCHEDULE OF FUTURE MINIMUM PAYMENT UNDER NOTES PAYABLES
SCHEDULE OF FUTURE LEASE PAYMENTS UNDER OPERATING LEASES
SCHEDULE OF STOCK OPTION PLAN ACTIVITY
SCHEDULE OF FAIR VALUE ASSUMPTIONS
SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY
SCHEDULE OF PERFORMANCE STOCK UNITS ACTIVITY
SCHEDULE OF STOCK BASED COMPENSATION GRANTED TO EMPLOYEES, DIRECTORS AND CONSULTANTS
SCHEDULE OF SEGMENT NET REVENUES
SCHEDULE OF REVENUES BY SEGMENT
SCHEDULE OF PERFORMANCE STOCK UNITS
Consolidation basis description
Beginning balance
Change in expected credit losses
Write-offs, net of recoveries
Ending balance
Platform Operator, Crypto Asset [Table]
Platform Operator, Crypto Asset [Line Items]
Carrying value
Fair value
Numerator - net income (loss)
Net income loss per share, basic
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock equivalents effect anti-dilutive
Dilutive common equivalent shares
Numerator - net income
Weighted average number of shares outstanding, basic
Dilutive common equivalents
Weighted average number of shares outstanding, diluted
Net income per share, diluted
Principal amount
Outstanding principal amount
Stock options, unvested RSUs, and unvested PSUs
Shares underlying vestred RSU
Effective income tax rate
Federal income tax rate
Unrecognized tax benefits
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning, balance
Accruals/Adjustments
Credits Taken Against Reserve
Ending, balance
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Line Items]
Raw materials
Work in progress
Finished goods
Total inventories
Prepaid insurance
Prepaid computer software licenses and related expenses
Prefunded co-pay assistance
Other prepaid expenses
Receivable due from Melt
Annual Prepaid Prescription Drug User (“PDUFA”) fees
Deposits and other current assets
Total prepaid expenses and other current assets
Computer hardware
Furniture and equipment
Lab and pharmacy equipment
Leasehold improvements
Property, plant and equipment, gross
Accumulated depreciation
Property, plant and equipment, net
Depreciation and amortization expenses
Intangible Asset, Finite-Lived [Table]
Finite-Lived Intangible Assets [Line Items]
Total gross capitalized software for internal-use
Accumulated amortization
Total capitalized software costs net
Amortization expenses
Intangible assets, Useful life
Intangible assets, Cost
Intangible assets, Accumulated amortization
Disposal
Intangible assets, Net Carrying value
Useful life, description
Amortization expense of intangible assets
Remainder of 2025
2026
2027
2028
2029
Thereafter
Intangible assets
Carrying value of goodwill
Accounts payable
Accrued interest (see Note 10)
Other accrued expenses
Total accounts payable and accrued expenses
Short-Term Debt [Table]
Short-Term Debt [Line Items]
Notes payable current, gross
Notes payable non-current, gross
Less: Unamortized debt issuance costs
Notes payable current, net
Less: Unamortized debt issuance costs
Notes payable non-current, net
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
Maturity period
Remainder of 2025
2026
2027
Total minimum payments
Less: amount representing interest payments
Notes payable, gross principal amount due
Less: current portion, net of unamortized discount
Less: unamortized debt issuance costs, net of premium
Notes payable, net of unamortized discount, net of current portion
Laon maximum borrowing capacity
Proceeds from line of credit
Commitment fee percentage for undrawn amount
Payment of costs
Debt discount
Interest expense other than long term debt
Amortization of financing costs and discount
Face amount
Interest rate
Debt instrument increase (decrease) for period net
Shares issued price per share
Proceeds from issuance of debt
Deducting underwriting discounts and commissions and expenses
Interest expense debt
Debt instrument unamortized premium
Interest rate, during period
Debt instrument maturity date
Redemption description
Schedule Of Future Lease Payments Under Operating Leases
Remainder of 2025
2026
2027
2028
2029
Thereafter
Total minimum lease payments
Less: amount representing interest payments
Total operating lease obligations
Less: current portion, operating lease obligations
Lessee, operating lease, remaining lease term
Area of land
Lease expiration date, description
Weighted average incremental borrowing rate
Weighted average remaining lease term
Operating lease payments
Operating lease expense
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares, outstanding, beginning balance
Weighted average exercise price, outstanding, beginning balance
Number of shares, options granted
Weighted average exercise price, options granted
Number of shares, options exercised
Weighted average exercise price, options exercised
Number of shares, options cancelled/forfeited
Weighted average exercise price, options cancelled/forfeited
Number of shares, outstanding, ending balance
Weighted average exercise price, outstanding, ending balance
Weighted average. remaining contractual life, options outstanding
Aggregate intrinsic value, options outstanding
Number of shares, options exercisable
Weighted average exercise price, options exercisable
Weighted average. remaining contractual life, options exercisable
Aggregate intrinsic value, options exercisable
Number of shares, options vested and expected to vest
Weighted average exercise price, options vested and expected to vest
Weighted average. remaining contractual life, options vested and expected to vest
Aggregate intrinsic value, options exercisable
Weighted-average fair value of options granted
Expected terms (in years)
Expected volatility
Risk-free interest rate
Dividend yield
Share-Based Payment Arrangement, Option, Exercise Price Range [Table]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices, minimum
Range of Exercise Prices, maximum
Number of Options Outstanding
Weighted Average Remaining Contractual Life in Years
Weighted Average Exercise Price, Outstanding
Number of Options Exercisable
Weighted Average Exercise Price, Exercisable
Number of Shares, unvested, outstanding, beginning balance
Weighted average grant date fair value, beginning balance
Number of Shares, RSUs granted
Weighted average grant date fair value, RSUs granted
Number of Shares, RSUs vested
Weighted average grant date fair value, RSUs vested
Number of Shares, RSUs cancelled/forfeited
Weighted average grant date fair value, RSUs cancelled/forfeited
Number of Shares, unvested, outstanding, ending balance
Weighted average grant date fair value, ending balance
Number of Shares, PSUs granted
Number of Shares, PSUs vested
Weighted average grant date fair value, beginning balance
Number of Shares, PSUs cancelled/forfeited
Total
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares granted
Number of share issued
Shares withheld for tax withholding obligation, shares
Payroll tax obligations, value
Proceeds from stock option exercised
Exercise of option, shares
Exercise price, minimum
Exercise price, maximum
Number of shares issued of common stock
Number of shares vested of common stock
Number of shares issued for services
Closing price of common stock price per share
Vesting term description
Forfeiture factor rate
Unrecognized compensation expense
Weighted-average period years
Stock-based compensation
Intrinsic value of options exercised
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Legal settlements
Punitive damages
Actual damages
Description of licenses agreements
Royalty expense
Upfront and milestone payments
Payment of minimum annual order amounts
Schedule of Segment Reporting Information, by Segment [Table]
Segment Reporting Information [Line Items]
Cost of sales
Gross profit
Operating expenses
Operating expenses
Income (loss) from operations
Segment Reporting, Revenue from External Customer, Product and Service [Table]
Revenue from External Customer [Line Items]
Revenue
Schedule of Revenue by Major Customers, by Reporting Segments [Table]
Revenue, Major Customer [Line Items]
Concentration risk percentage
Subsequent Event [Table]
Subsequent Event [Line Items]
Target Share Price
Number of Shares
Share issue
Shares withheld for tax withholding obligation
Additional shares withheld for tax withholding obligation
Share price
875 Senior Notes Due 2027 [Member]
625 Senior Notes Due 2026 [Member]
Accrued rebates and copay assistance.
Payment of payroll taxes upon vesting of PSUs, RSUs and exercise of stock options.
Change in right-of-use assets for operating lease obligations assumptions.
Consolidation basis, description.
Oaktree Loan [Member]
Oaktree Fund Administration LLC [Member]
Senior Secured Term Loan [Member]
2026 Notes [Member]
2027 Notes [Member]
Tranche B [Member]
Stock Options, Unvested RSUs And Unvested PSUs [Member]
Oaktree Credit Agreement Amendment [Member]
Santen Products Acquisition [Member]
Second Amendment [Member]
8.625% Senior Notes Due 2026 [Member]
11.875% Senior Notes Due 2027 [Member]
Schedule Of Valuation And Qualifying Accounts Disclosure [Table Text Block]
Chargebacks [Member]
Government Rebates [Member]
Allowances For Sales Returns [Member]
Administrative Fees and Other Rebates [Member]
Co Pay Assistance [Member]
Reserves For Cash Discount [Member]
Notes payable current gross.
Long term notes payable gross.
Prepaid computer software licenses and related expenses.
Prefunded co-pay assistance.
Receivable due from related party.
Prepaid prescription drug user fees.
Computer hardware gross.
Capitalized Software Costs [Text Block]
Capitalized Software Development Costs [Table Text Block]
Capitalized Software Development Costs [Member]
Office and Laboratory Space [Member]
Ledgewood [Member]
Lease expiration date description.
Nashville [Member]
Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Licenses [Member]
Acquired NDAs [Member]
State Pharmacy Licenses [Member]
Finite lived intangible assets disposal
Andrew R. Boll [Member]
Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Mark L. Baum [Member]
John P Saharek [Member]
Prior Periods [Member]
RSU and PSU [Member]
Stock Option Plan [Member]
Employees and Consultant [Member]
Forfeiture factor rate.
Employees and Directors [Member]
Range One [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Range Six [Member]
Range Seven [Member]
Range Eight [Member]
Range Nine [Member]
Range Ten [Member]
CommonStock 0.001 Par Value Per Share [Member]
Risks Uncertainties And Liquidity [Policy Text Block]
Senior Notes Due April 2026 [Member]
April 2023 [Member]
Asset Purchase, License and Related Agreements [Member]
Upfront and milestone payments.
Asset Purchase and License Agreements [Member]
Description of licenses agreements.
Formosa Agreement [Member]
Branded [Member]
Compounding [Member]
Product Sales Net [Member]
Reportable Segment Aggregation Research and Development [Member]
Schedule Of Segment Reporting Information [Text Block]
IHEEZO [Member]
VEVYE [Member]
Other Products [Member]
Other Revenue [Member]
ImprimisRx [Member]
Two Customer [Member]
One Customer [Member]
Customer [Member]
Two Suppliers [Member]
Purchases [Member]
Three Suppliers [Member]
Addtional shares paid for tax withholding for share based compensation.
Performance Stock Units PSU [Member]
Share Based Compensation Award Tranche Four [Member]
Antidilutive securities excluded from computation of earnings per shares.
Other Revenues [Member]
Third Party Software License [Member]
Oaktree Loan due January 2026 [Member]
Employees [Member]
Consultants [Member]
Assets, Current
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Equity, Including Portion Attributable to Noncontrolling Interest
Liabilities and Equity
Interest Expense, Nonoperating
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income Tax Expense (Benefit)
Shares, Outstanding
Stock Issued During Period, Value, Other
Stock Issued During Period, Shares, Other
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Employee Related Liabilities
Increase (Decrease) in Deferred Revenue
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Intangible Assets
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Payment of payroll taxes upon vesting of PSUs, RSUs and exercise of stock options
Payments of Debt Issuance Costs
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Accounts Receivable, Allowance for Credit Loss, Current
Accounts Receivable, Allowance for Credit Loss, Writeoff
Effective Income Tax Rate Reconciliation, Percent
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Capitalized Computer Software, Accumulated Amortization
Finite-Lived Intangible Assets, Net
Debt Instrument, Unamortized Discount, Current
Debt Instrument, Unamortized Discount, Noncurrent
Long-Term Debt, Maturity, Remainder of Fiscal Year
Long-Term Debt, Maturity, Year One
Long-Term Debt, Maturity, Year Two
Long-Term Debt
Prepaid Interest
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Lessee, Operating Lease, Liability, to be Paid, Year One
Lessee, Operating Lease, Liability, to be Paid, Year Two
Lessee, Operating Lease, Liability, to be Paid, Year Three
Lessee, Operating Lease, Liability, to be Paid, Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period